Nucleic acid-based testing for noninfluenza pathogens suggested for hospitalized patients who have severe CAP or are immunocompromised
NIH Starts Trial Assessing ‘Mix & Match’ COVID-19 Vaccine Approach
Individuals who received J&J, Moderna, or Pfizer-BioNTech vaccine will receive single booster dose of Moderna vaccine 12 to 20 weeks later
- Page 2 of 2
- 1
- 2